Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Stomatitis × Fibroblast Growth Factor 7 × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomatitis 1 Neoplasms 1 Colonic Neoplasms 1

Interventions

aluminum hydroxide, magnesium hydroxide, drug combination 1 alfacalcidol 1 Zinc Acetate 1 Vitamin E 1 Low-Level Light Therapy 1 Lidocaine 1 Hydrogels 1 Fibroblast Growth Factor 7 1 Diphenhydramine 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00393822 2014-07-15

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

Amgen

Phase 2/3 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡